Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-22
2010-06-29
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S013800, C514S014800, C530S324000
Reexamination Certificate
active
07745390
ABSTRACT:
Artificial antimicrobial peptides are obtained by alterations in alpha helical portions of a known antimicrobial protein, granulysin. The peptides obtained have significantly improved antimicrobial activity and lack the ability to lyse mammalian cells, which may be toxic to a host. The peptides may be designed according to certain guidelines, and may further be modified by the addition of altered residues and alterations in normal peptide secondary and tertiary structure, including modifications in quaternary (multimeric) structure.
REFERENCES:
patent: 6485928 (2002-11-01), Stenger et al.
patent: WO 99/22755 (1999-05-01), None
patent: WO 2005/090385 (2005-09-01), None
Wang et. al., J. Immunol., 2000, vol. 165, pp. 1486-1490.
Zhuo Wang, et al., “Bactericidal and Tumoricidal Activities of Synthetic Peptides Derived from Granulysin,”The Journal of Immunology, 2000, 165: 1486-1490.
Anmei Deng, et al., “Granulysin, a Cytolytic Molecule, Is Also a Chemoattractant and proinflammatory activator,”The Journal of Immunology, 2005, 174: 5243-5248.
William A. Ernst, et al., “Granulysin, a T Cell Product, Kills bacteria by Altering Membrane Permeability”The Journal of Immunology, 2000, 165: 7102-7108.
Alan M. Krensky, et al., “Granulysin: A Novel Host Defense Molecule,”American Journal of Transplantation, Aug. 2005, 5: 1789-1792.
Qing LI, et al., “Hemolysis of Erythrocytes by Granulysin-Derived Peptides but Not by Granulysin,”Antimicrobial Agents and Chemotherapy, Jan. 2005, vol. 49, No. 1, 388-397.
Ayyalusamy Ramamoorthy, et al., “Cell selectivity correlates with membrane-specific interactions: A case study on the antimicrobial peptide G15 derived from granulysin,”Biochimica et Biophysica Acta1758:154-163, Mar. 2006.
Clayberger Carol
Krensky Alan M.
Aston David J.
Peters Verny LLP
Tate Christopher R.
Teller Roy
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Antimicrobial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4250200